Praxis Precision Medicines (NASDAQ:PRAX – Free Report) had its price objective trimmed by Truist Financial from $175.00 to $85.00 in a research note released on Monday morning,Benzinga reports. The ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback